AVBP vs CHRW · $1.39B cap vs P/E 37, rev $8.95B
ArriVent BioPharma, Inc. Common Stock (AVBP) versus CH Robinson Worldwide Inc (CHRW) — a side-by-side from cached financials, not a winner call.
ArriVent BioPharma, Inc. Common Stock (AVBP) is a biotechnology company listed on US.
CH Robinson Worldwide Inc (CHRW) is a integrated freight & logistics company listed on US.
AVBP does not have a complete income-statement cache yet.
Latest reported CHRW revenue for 2026-06-30 was $8.95B. Net income was $334.0M. CHRW currently screens at market cap $21.70B and trailing P/E 37.3.
AVBP currently screens at market cap $1.39B. CHRW currently screens at market cap $21.70B and trailing P/E 37.3.
Not investment advice. Open the AVBP and CHRW stock pages for the full models.
Not investment advice.